GE HealthCare Trims 2025 Outlook, 1Q Results Increase from Year Earlier

Dow Jones
昨天
 

By Denny Jacob

 

GE HealthCare trimmed its estimates for the year after assuming the impact of tariffs on its outlook.

The maker of magnetic-resonance imaging scanners and other health-care machines now expects adjusted earnings per-share to be in the range of $3.90 to $4.10. It previously guided for adjusted earnings between $4.61 a share and $4.75 a share.

Free cash flow is now expected to be at least $1.2 billion, down from prior guidance calling for at least $1.75 billion.

Chief Executive Peter Arduini said the company is actively driving mitigation actions in regards to the current global trade environment.

The Chicago company logged net income of $564 million, or $1.23 a share, up from $374 million, or 81 cents a share, in the prior-year period.

Stripping out certain one-time items, earnings came in at $1.01 a share. Analysts polled by FactSet expected 91 cents a share.

Revenue rose to $4.78 billion from $4.65 billion. Analysts polled by FactSet expected $4.66 billion.

GE HealthCare said revenue growth was broad-based with growth in each segment, with overall strength in the U.S.

GE HealthCare also announced its board authorized the repurchase of up to $1 billion of the company's common stock.

 

Write to Denny Jacob at denny.jacob@wsj.com

 

(END) Dow Jones Newswires

April 30, 2025 07:12 ET (11:12 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10